283 related articles for article (PubMed ID: 19192423)
1. Metabolic syndrome associated with HIV and highly active antiretroviral therapy.
Barbaro G; Iacobellis G
Curr Diab Rep; 2009 Feb; 9(1):37-42. PubMed ID: 19192423
[TBL] [Abstract][Full Text] [Related]
2. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
Barbaro G
Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk.
Barbaro G
Am J Ther; 2006; 13(3):248-60. PubMed ID: 16772767
[TBL] [Abstract][Full Text] [Related]
4. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G; Barbarini G
Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
7. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
[TBL] [Abstract][Full Text] [Related]
8. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
Grinspoon SK
Am J Med; 2005 Apr; 118 Suppl 2():23S-28S. PubMed ID: 15903292
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.
Barbaro G; Klatt EC
Curr Pharm Des; 2003; 9(18):1475-81. PubMed ID: 12769727
[TBL] [Abstract][Full Text] [Related]
11. HIV infection, highly active antiretroviral therapy and the cardiovascular system.
Barbaro G
Cardiovasc Res; 2003 Oct; 60(1):87-95. PubMed ID: 14522410
[TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy and the cardiovascular system: the heart of the matter.
Barbaro G
Pharmacology; 2003 Dec; 69(4):177-9. PubMed ID: 14624056
[TBL] [Abstract][Full Text] [Related]
13. Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection.
Barbaro G
Clin Ter; 2008; 159(1):51-5. PubMed ID: 18399263
[TBL] [Abstract][Full Text] [Related]
14. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome.
Iacobellis G; Sharma AM; Pellicelli AM; Grisorio B; Barbarini G; Barbaro G
Curr HIV Res; 2007 Mar; 5(2):275-9. PubMed ID: 17346142
[TBL] [Abstract][Full Text] [Related]
15. HIV and increased risk of cardiovascular diseases.
Das S
Sex Health; 2005; 2(4):219-21. PubMed ID: 16402668
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
Anuurad E; Semrad A; Berglund L
Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
[TBL] [Abstract][Full Text] [Related]
17. The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines.
Palios J; Kadoglou NP; Lampropoulos S
Exp Diabetes Res; 2012; 2012():103063. PubMed ID: 22203832
[TBL] [Abstract][Full Text] [Related]
18. HAART-associated body habitus and metabolic changes, Part 1.
Liss M; Boyle BA
AIDS Read; 2000 Nov; 10(11):622, 629-31. PubMed ID: 11186180
[No Abstract] [Full Text] [Related]
19. Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?
Cossarizza A; Mussini C; Viganò A
Bioessays; 2001 Nov; 23(11):1070-80. PubMed ID: 11746223
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART.
Cahn P; Leite O; Rosales A; Cabello R; Alvarez CA; Seas C; Carcamo C; Cure-Bolt N; L'Italien GP; Mantilla P; Deibis L; Zala C; Suffert T
Braz J Infect Dis; 2010; 14(2):158-66. PubMed ID: 20563442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
